|
🐜
|
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer
24 auth.
P. Mu,
Zeda Zhang,
M. Benelli,
W. Karthaus,
Elizabeth A. Hoover,
Chi-Chao Chen,
John Wongvipat,
Sheng-Yu Ku,
D. Gao,
Z. Cao,
...
Neel Shah,
E. Adams,
W. Abida,
Philip A Watson,
D. Prandi,
Chun-Hao Huang,
E. de Stanchina,
S. Lowe,
L. Ellis,
H. Beltran,
M. Rubin,
D. Goodrich,
F. Demichelis,
C. Sawyers
|
9 |
2017 |
9
🐜
|
|
🐜
|
Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones
10 auth.
Deguang Liang,
Yan Feng,
Fereshteh Zandkarimi,
Hua Wang,
Zeda Zhang,
Jinnie Kim,
...
Yanyan Cai,
Wei Gu,
B. Stockwell,
Xuejun Jiang
|
8 |
2023 |
8
🐜
|
|
🐜
|
FOXA1 mutations alter pioneering activity, differentiation, and prostate cancer phenotypes
17 auth.
E. Adams,
W. Karthaus,
Elizabeth A. Hoover,
Deli Liu,
Antoine Gruet,
Zeda Zhang,
Hyunwoo Cho,
Rose DiLoreto,
S. Chhangawala,
Yang Liu,
...
Philip A Watson,
E. Davicioni,
A. Sboner,
C. Barbieri,
R. Bose,
C. Leslie,
C. Sawyers
|
7 |
2019 |
7
🐜
|
|
🦁
|
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
29 auth.
Zeda Zhang,
W. Karthaus,
Young Sun Lee,
Vianne R. Gao,
Chao Wu,
Joshua W. Russo,
Menghan Liu,
J. M. Mota,
W. Abida,
Eliot L. Linton,
Eugine Lee,
Spencer D. Barnes,
Hsuan-An Chen,
Ninghui Mao,
John Wongvipat,
...
Danielle Choi,
Xiaoping Chen,
Huiyong Zhao,
K. Manova-Todorova,
E. de Stanchina,
M. Taplin,
S. Balk,
D. Rathkopf,
A. Gopalan,
B. Carver,
P. Mu,
Xuejun Jiang,
Philip A Watson,
C. Sawyers
|
7 |
2020 |
7
🦁
|
|
🦁
|
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
32 auth.
Zeda Zhang,
Chuanli Zhou,
Xiaoling Li,
Spencer D. Barnes,
S. Deng,
Elizabeth A. Hoover,
Chi-Chao Chen,
Young Sun Lee,
Yanxiao Zhang,
Choushi Wang,
Lauren A Metang,
Chao Wu,
Carla Rodriguez Tirado,
N. A. Johnson,
John Wongvipat,
...
K. Navrazhina,
Z. Cao,
Danielle Choi,
Chun-Hao Huang,
Eliot L. Linton,
Xiaoping Chen,
Yupu Liang,
C. Mason,
E. de Stanchina,
W. Abida,
A. Lujambio,
Sheng Li,
S. Lowe,
J. Mendell,
V. Malladi,
C. Sawyers,
P. Mu
|
6 |
2020 |
6
🦁
|
|
🐜
|
ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis
17 auth.
R. Bose,
W. Karthaus,
J. Armenia,
W. Abida,
P. J. Iaquinta,
Zeda Zhang,
John Wongvipat,
E. Wasmuth,
Neel Shah,
P. Sullivan,
...
Michael G. Doran,
Ping Wang,
A. Patruno,
Yilin Zhao,
D. Zheng,
N. Schultz,
C. Sawyers
|
6 |
2017 |
6
🐜
|
|
🐜
|
Macrophages promote anti-androgen resistance in prostate cancer bone disease
21 auth.
Xue-Feng Li,
C. Selli,
Jian Cao,
Shuiqing Wu,
Ruo-Yu Ma,
Ye Lu,
Cheng-Bin Zhang,
Bijie Xun,
Alyson D. Lam,
Xiao Pang,
...
A. Fernando,
Zeda Zhang,
A. Unciti‐Broceta,
N. Carragher,
P. Ramachandran,
N. Henderson,
Ling-Ling Sun,
Hai-Yan Hu,
Guibo Li,
C. Sawyers,
Binzhi Qian
|
5 |
2023 |
5
🐜
|
|
🐜
|
A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon
12 auth.
D. Gao,
Yuhong Zhan,
W. Di,
Amanda R. Moore,
Jessica Sher,
Y. Guan,
...
Shangqian Wang,
Zeda Zhang,
Devan A Murphy,
C. Sawyers,
Ping Chi,
Yu Chen
|
4 |
2016 |
4
🐜
|
|
🐜
|
Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
18 auth.
Ninghui Mao,
Zeda Zhang,
Young Sun Lee,
Danielle Choi,
Aura C. Agudelo Rivera,
Dan Li,
Cindy J Lee,
S. Haywood,
Xiaoping Chen,
Q. Chang,
...
Guotai Xu,
Hsuan-An Chen,
E. de Stanchina,
C. Sawyers,
N. Rosen,
A. Hsieh,
Yu Chen,
B. Carver
|
4 |
2021 |
4
🐜
|
|
🐜
|
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
31 auth.
Xiaoling Li,
Yunguan Wang,
S. Deng,
Guanghui Zhu,
Choushi Wang,
N. A. Johnson,
Zeda Zhang,
Carla Rodriguez Tirado,
Yaru Xu,
Lauren A Metang,
Julisa Gonzalez,
Atreyi Mukherji,
Jianfeng Ye,
Yuqiu Yang,
W. Peng,
...
Yitao Tang,
Mia Hofstad,
Zhiqun Xie,
Heewon Yoon,
Liping Chen,
Xihui Liu,
Sujun Chen,
Hong Zhu,
Douglas W. Strand,
Han Liang,
Ganesh V Raj,
H. He,
J. Mendell,
Bo Li,
Tao Wang,
P. Mu
|
4 |
2023 |
4
🐜
|
